ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares (NQ: ARYD )

6.640 UNCHANGED

Last Price Updated: 3:59 PM EDT, Jul 31, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	6.640
Bid (Size)	7.500 (1)
Ask (Size)	8.600 (1)
Prev. Close	6.640
Today's Range	6.640 - 6.640
52wk Range	6.640 - 11.57
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias

July 31, 2024

From Adagio Medical, Inc.

Via Business Wire

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

May 06, 2024

From GENENTA SCIENCE SPA

Via GlobeNewswire

Performance

YTD	-39.25%	-39.25%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	-42.26%	-42.26%
1 Year	-39.14%	-39.14%

More News

Stocks That Hit 52-Week Lows On Friday

February 25, 2022

Via Benzinga

Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall

February 24, 2022

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

Via Benzinga

The Week In SPAC News - Sunday, Oct. 3

October 03, 2021

Via Talk Markets

Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business

September 29, 2021

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.